Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Sarin

Showing results (211-220 of 228) with videos related to

Pageof 23
Sort By:
Journal of Forensic Sciences|November 1, 1989
Inactivation of human immunodeficiency virus (HIV) by ionizing radiation in body fluids and serological evidenceP D Bigbee, P S Sarin, J C Humphreys, et al.
International Journal of Cancer|June 15, 1985
Regional variation in prevalence of antibody against human T-lymphotropic virus types I and III in Kenya, East AfricaR J Biggar, B K Johnson, C Oster, et al.
Cellular Immunology|March 1, 1986
The relationship of abnormalities of cellular immunity to antibodies to HTLV-III in homosexual menB S Dobozin, F N Judson, D L Cohn, et al.
AIDS Research and Human Retroviruses|August 1, 1992
A phase I study of HGP-30, a 30 amino acid subunit of the human immunodeficiency virus (HIV) p17 synthetic peptide analogue sub-unit vaccine in seronegative subjectsJ O Kahn, D P Stites, J Scillian, et al.
The Journal of Clinical Investigation|June 1, 1984
Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factorT A Waldmann, W C Greene, P S Sarin, et al.
Lancet (London, England)|December 22, 1984
HTLV-III seropositivity in European haemophiliacs exposed to Factor VIII concentrate imported from the USAM Melbye, K S Froebel, R Madhok, et al.
International Journal of Cancer|September 15, 1982
The human type-C retrovirus, HTLV, in Blacks from the Caribbean region, and relationship to adult T-cell leukemia/lymphomaW A Blattner, V S Kalyanaraman, M Robert-Guroff, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1989
Comparison of a human T-cell lymphotropic virus type I strain from cerebrospinal fluid of a Jamaican patient with tropical spastic paraparesis with a prototype human T-cell lymphotropic virus type IP S Sarin, P Rodgers-Johnson, D K Sun, et al.
Lancet (London, England)|January 5, 1985
Infection of chimpanzees by human T-lymphotropic retroviruses in brain and other tissues from AIDS patientsD C Gajdusek, H L Amyx, C J Gibbs, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
Specific antibody responses to synthetic peptides of HIV-1 p17 correlate with different stages of HIV-1 infectionJ D Jiang, F N Chu, P H Naylor, et al.
Pageof 23

Showing results (211-220 of 228) with videos related to

Sort By:
Pageof 23
Journal of Forensic Sciences|November 1, 1989
Inactivation of human immunodeficiency virus (HIV) by ionizing radiation in body fluids and serological evidenceP D Bigbee, P S Sarin, J C Humphreys, et al.
International Journal of Cancer|June 15, 1985
Regional variation in prevalence of antibody against human T-lymphotropic virus types I and III in Kenya, East AfricaR J Biggar, B K Johnson, C Oster, et al.
Cellular Immunology|March 1, 1986
The relationship of abnormalities of cellular immunity to antibodies to HTLV-III in homosexual menB S Dobozin, F N Judson, D L Cohn, et al.
AIDS Research and Human Retroviruses|August 1, 1992
A phase I study of HGP-30, a 30 amino acid subunit of the human immunodeficiency virus (HIV) p17 synthetic peptide analogue sub-unit vaccine in seronegative subjectsJ O Kahn, D P Stites, J Scillian, et al.
The Journal of Clinical Investigation|June 1, 1984
Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factorT A Waldmann, W C Greene, P S Sarin, et al.
Lancet (London, England)|December 22, 1984
HTLV-III seropositivity in European haemophiliacs exposed to Factor VIII concentrate imported from the USAM Melbye, K S Froebel, R Madhok, et al.
International Journal of Cancer|September 15, 1982
The human type-C retrovirus, HTLV, in Blacks from the Caribbean region, and relationship to adult T-cell leukemia/lymphomaW A Blattner, V S Kalyanaraman, M Robert-Guroff, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1989
Comparison of a human T-cell lymphotropic virus type I strain from cerebrospinal fluid of a Jamaican patient with tropical spastic paraparesis with a prototype human T-cell lymphotropic virus type IP S Sarin, P Rodgers-Johnson, D K Sun, et al.
Lancet (London, England)|January 5, 1985
Infection of chimpanzees by human T-lymphotropic retroviruses in brain and other tissues from AIDS patientsD C Gajdusek, H L Amyx, C J Gibbs, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
Specific antibody responses to synthetic peptides of HIV-1 p17 correlate with different stages of HIV-1 infectionJ D Jiang, F N Chu, P H Naylor, et al.
Pageof 23